# Female breast cancer IPD anthracyclines
*** R syntax of main analyses (Nature Medicine 2023) ***

**Title**: Female breast cancer risk after anthracyclines for childhood cancer: An international pooled analysis

**Authors**: Yuehan Wang, Cécile M. Ronckers, Flora E. van Leeuwen, Chaya S. Moskowitz, Wendy Leisenring, Gregory T. Armstrong, Florent de Vathaire, Melissa M. Hudson, Claudia E. Kuehni, Michael A. Arnold, Charlotte Demoor-Goldschmidt, Daniel M. Green, Tara O. Henderson, Rebecca M. Howell, Matthew J. Ehrhardt, Joseph P. Neglia, Kevin C. Oeffinger, Helena J. van der Pal, Leslie L. Robison, Michael Schaapveld, Lucie M. Turcotte, Nicolas Waespe, Leontien C.M. Kremer, Jop C. Teepen

**Collaborators**: Nadia Haddy, Ibrahima Diallo, K. Scott Baker, Amy Berrington de González, Miriam R. Conces, Louis S. Constine, Mike Hawkins, Geert O. Janssens, Lene Mellemkjaer, Raoul Reulen, Jeanette F. Winther

On behalf of The International Consortium for Pooled Studies on Subsequent Malignancies after Childhood and Adolescent Cancer
